Floatz logo

SODIUM P-AMINOHIPPURATE

Pre Diabetes

Petter BjornstadSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

45 Active assets in the Pre Diabetes cohort.

Asset / SponsorPhaseRating
Metformin
Yu Chen
Phase 4A
Liraglutide
Woman's
Phase 4BBB
Exenatide
RenJi Hospital
Phase 4BBB
Semaglutide
The University of Texas Health Science Center at San Antonio
Phase 4BBB
Semaglutide
Esbjerg Hospital - University Hospital of Southern Denmark
Phase 4BBB

View all 50 →

Same molecule, other indications

SODIUM P-AMINOHIPPURATE is also rated in:

diabetic kidney diseaseDormant
CCC
Indicative ·
52 / 100
View asset →
Diabetes ComplicationsDormant
CCC
Indicative ·
52 / 100
View asset →
type 2 diabetes mellitusDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →